Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on the Use of Canakinumab Administered Subcutaneously in the Treatment of Patients With COVID-19 Pneumonia

NCT04348448 is registered in ClinicalTrials.gov with AUSL Romagna Rimini as lead sponsor.

NCT NCT04348448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04348448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on the Use of Canakinumab Administered Subcutaneously in the Treatment of Patients With COVID-19 Pneumonia
Lead sponsor
AUSL Romagna Rimini
Phase
Observational
Overall status
Terminated
Start date
February 1, 2020
Completion date
September 1, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19